Effect of hypothermia and delayed thrombolysis in a rat embolic stroke model

Acta Neurol Scand. 1994 Aug;90(2):91-8. doi: 10.1111/j.1600-0404.1994.tb02686.x.

Abstract

Effect of hypothermia on cerebral infarcts was studied in rats embolized in the right carotid territory. Thirty-four served as normothermic controls receiving saline infusion only. In 16 rats hypothermia of 32 degrees C was induced by cooling with a fan, followed by embolization. The rats were kept hypothermic for the following 3 h before body temperature was raised to 37 degrees C. In 26 rats, treatment with human recombinant tissue plasminogen activator (20 mg/kg i.v. during 45 min), started 2 h after embolization. Finally, 14 rats were treated similarly with hypothermia for 3 h followed by additional rt-PA treatment starting after 2 h. Thrombolytic therapy reduced median infarct volume from 19.5% of affected hemisphere among controls to 4.6% (p = 0.006) in the treated group. Three hours of hypothermia reduced infarct volume to 1.6% (p = 0.0007). Additional rt-PA could not demonstrate further improvement in this experimental setting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Flow Velocity / physiology
  • Body Temperature Regulation / physiology*
  • Carotid Artery Thrombosis / pathology
  • Carotid Artery Thrombosis / physiopathology*
  • Carotid Artery, Internal / diagnostic imaging
  • Carotid Artery, Internal / pathology
  • Cerebral Angiography
  • Cerebral Arteries / pathology
  • Cerebral Infarction / pathology
  • Cerebral Infarction / physiopathology
  • Disease Models, Animal
  • Hypothermia, Induced*
  • Intracranial Embolism and Thrombosis / pathology
  • Intracranial Embolism and Thrombosis / physiopathology*
  • Observer Variation
  • Rats
  • Recombinant Proteins / pharmacology
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / pharmacology

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator